Acute Asthma Clinical Trial
Official title:
Feasibility of an ED-initiated Online Asthma Management Program for Urban Teens (Puff City-ED)
The objective of this study is to determine the feasibility of conducting a randomized controlled trial to evaluate the effectiveness of an online, Emergency Department-initiated asthma management intervention designed to reduce asthma-related morbidity among urban teenagers aged 13-19 years with uncontrolled asthma. The study will examine issues around recruitment, participant compliance with the study protocol, Internet access, and attrition. Investigators will first develop a protocol for recruiting 13-19 year old patients with acute asthma into an ED-initiated pilot trial of an online asthma management program, describing recruitment and refusal rates. Investigators will measure participant compliance with the pilot study protocol including 4 online sessions and a 6 month survey. Investigators will also measure compliance of the participants parents at baseline and a six month follow up. Investigators will then use pilot study results to describe the intervention effect on selected outcomes including ED visits, asthma control as measured by Asthma Control Questionnaire, functional limitations, quality of life, and behavior change.
Participating emergency departments include Henry Ford Main, Henry Ford Fairlane, and
Detroit Medical Center Children's hospital. Eligible teens will be 13-19 years of age.
(Including 19 year olds in the the proposed sample means the data is comparable to age
categories used by many federal agencies). Eligibility criteria include: a physician
diagnosis of acute asthma at the ED visit and parent and teen written informed
consent/assent. Eligibility criteria can be confirmed with the help of the ED nursing staff
as some teens presenting with symptoms of acute asthma, may receive an asthma diagnosis for
the first time in the ED. Using the investigator's data from the school-based trial of Puff
City, investigators observed that 12.9% (20/155) of teens reporting an ED visit at baseline
also reported no physician diagnosis. This is used as an approximation of the number of
participants in the ED pilot that may be newly diagnosed. Teens previously enrolled in the
school-based version of Puff City will not be eligible to participate in this pilot.
Eligible teens are approached by a recruiter during down time in the ER (while waiting
during receiving treatment or while waiting to be discharged). A study recruiter will
provide the teen with an enrollment packet that includes an informational brochure (SD 1), a
consent (SD 2), and an assent form (SD 3). The recruiter will go through these materials
with the parents and teens and answer any questions they may have about the program. The
recruited teens who enroll are randomized to either treatment or control. Both groups will
be asked to complete an online baseline questionnaire before leaving the ED. An example of
this questionnaire has been included with this application (SD 4). Once the baseline
questionnaire is finished, teens will then be completing 4 online sessions of web-based
asthma education on their own time on a computer with Internet access. Control group will
receive commercial websites such as those sponsored by the American Lung Association; the
American Academy of Allergy, Asthma and Immunology; the Asthma and Allergy Foundation, and
others. Treatment group receives the 4 online, tailored educational sessions. Teens will be
encouraged to complete the 4 sessions within 90 days, with a minimum of 7 days between
sessions to allow for behavior change. To regulate dosage, control participants receive a
"time expired" message after 30 minutes of browsing; this time limit is commensurate with
the estimated time needed to complete a tailored session. Teens will also be asked to
complete a 6-month follow-up survey (SD 5).Parents/Guardians of the enrolled teens will also
be asked to complete a baseline questionnaire and a follow-up at 6 months (SD 6-7) in the
form of a telephone interview with a trained interviewer.
In YR1 investigators will develop the recruitment protocol, hire and train recruiters, and
establish a study database. Investigators will get on the agenda of CHM ED staff meetings to
orient clinic staff to the intervention, obtain input/feedback, discuss logistics, address
concerns, and answer questions about the project. Prior to recruitment Investigators will
develop signage about the study (as appropriate) for the ED. Recruitment will start in month
six of YR1, with at least two practice runs of the protocol. In YR2, investigators will
continue recruitment and begin 6 month follow-up surveys. Recruitment will end in the fall
of YR2 leaving 6-8 months for completion of follow-up, analysis and write-up. At the end of
YR1 and again at the end of YR2, investigators will conduct short, qualitative interviews
with ED and research staff to ensure identification of issues, barriers, and obstacles to
conducting a trial of an ED-initiated version of Puff City.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01429415 -
Magnesium Nebulization Utilization in Management of Pediatric Asthma
|
Phase 2 | |
Completed |
NCT01196377 -
Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
|
N/A | |
Completed |
NCT00733317 -
Budesonide for Emergency Treatment of Acute Wheezing in Children
|
Phase 4 | |
Completed |
NCT00733473 -
Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing
|
Phase 4 | |
Recruiting |
NCT04016220 -
Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
|
Phase 1 | |
Active, not recruiting |
NCT06005337 -
Supporting Parents to Choose Wisely
|
N/A | |
Completed |
NCT01079000 -
Emergency Department (ED)-Directed Interventions to Improve Asthma Outcomes
|
N/A | |
Completed |
NCT00922350 -
Heliox and Posture in Patients With Asthma
|
N/A | |
Completed |
NCT03698630 -
Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children
|
Phase 4 | |
Terminated |
NCT00819637 -
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
|
Phase 4 | |
Completed |
NCT01868113 -
Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
|
Phase 3 | |
Completed |
NCT01016444 -
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
|
||
Completed |
NCT00393367 -
Budesonide Inhalation Suspension for Acute Asthma in Children
|
Phase 4 | |
Completed |
NCT03369119 -
Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children
|
Phase 4 | |
Completed |
NCT01304901 -
Effect of Addition of Single Dose of Oral Montelukast to Standard Treatment in Acute Asthma in Preschool Children.
|
Phase 4 | |
Completed |
NCT01403467 -
Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation
|
Phase 4 |